Detalles de la búsqueda
1.
Diagnostic and therapeutic approach to pulmonary infiltrates in cancer patients receiving immune checkpoint inhibitors.
Rev Esp Quimioter;
35 Suppl 3: 67-73, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36285862
2.
Correction to: Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies.
Open Forum Infect Dis;
9(6): ofac180, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35615301
3.
Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies.
Open Forum Infect Dis;
8(6): ofab250, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34104670
4.
Assessment of latent infections in patients receiving biological therapies.
Rev Esp Quimioter;
32 Suppl 2: 63-68, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31475814
5.
Regular monitoring of cytomegalovirus-specific cell-mediated immunity in intermediate-risk kidney transplant recipients: predictive value of the immediate post-transplant assessment.
Clin Microbiol Infect;
25(3): 381.e1-381.e10, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29803844
6.
Achromobacter xylosoxidans bacteremia: clinical and microbiological features in a 10-year case series.
Rev Esp Quimioter;
31(3): 268-273, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29806765
7.
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors).
Clin Microbiol Infect;
24 Suppl 2: S53-S70, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29454849
8.
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors).
Clin Microbiol Infect;
24 Suppl 2: S21-S40, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29447987
9.
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52).
Clin Microbiol Infect;
24 Suppl 2: S71-S82, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29447988
10.
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents).
Clin Microbiol Infect;
24 Suppl 2: S10-S20, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29459143
11.
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Introduction).
Clin Microbiol Infect;
24 Suppl 2: S2-S9, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29427801
12.
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors).
Clin Microbiol Infect;
24 Suppl 2: S95-S107, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29427804
13.
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Cell surface receptors and associated signaling pathways).
Clin Microbiol Infect;
24 Suppl 2: S41-S52, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29426804
14.
Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations.
Transplant Rev (Orlando);
32(1): 36-57, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28811074
15.
Comparison of the clinical course of Clostridium difficile infection in glutamate dehydrogenase-positive toxin-negative patients diagnosed by PCR to those with a positive toxin test.
Clin Microbiol Infect;
24(4): 414-421, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28811244
16.
Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation.
Clin Microbiol Infect;
24(2): 192-198, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28652112
17.
Pathogen-related factors affecting outcome of catheter-related bacteremia due to methicillin-susceptible Staphylococcus aureus in a Spanish multicenter study.
Eur J Clin Microbiol Infect Dis;
36(10): 1757-1765, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28477236
18.
No evidence of increased ocular involvement in candidemic patients initially treated with echinocandins.
Diagn Microbiol Infect Dis;
88(2): 141-144, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28366609
19.
Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance.
Clin Microbiol Infect;
23(9): 672.e1-672.e11, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28143788
20.
Significance of the isolation of Staphylococcus aureus from a central venous catheter tip in the absence of concomitant bacteremia: a clinical approach.
Eur J Clin Microbiol Infect Dis;
35(11): 1865-1869, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27477854